NATURE’S SUNSHINE PRODUCTS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $500.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2024-03-12
- NATURE’S SUNSHINE PRODUCTS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $500.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$9.40M.
- NATURE’S SUNSHINE PRODUCTS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was -$6.60M.
- NATURE’S SUNSHINE PRODUCTS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was -$6.10M, a 654.55% decline from fiscal 2019.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2023-12-31 | $500.00K 10-K · filed 2024-03-12 |
| 2022-12-31 | -$9.40M 10-K · filed 2023-03-16 |
| 2021-12-31 | -$6.60M 10-K · filed 2022-03-08 |
| 2020-12-31 | -$6.10M 10-K · filed 2021-03-10 |
| 2019-12-31 | $1.10M 10-K · filed 2020-03-11 |
| 2018-12-31 | -$3.80M 10-K · filed 2019-03-08 |
| 2017-12-31 | $12.80M 10-K · filed 2018-03-16 |
| 2016-12-31 | $4.70M 10-K · filed 2017-03-14 |
| 2015-12-31 | -$6.60M 10-K · filed 2016-03-14 |
| 2014-12-31 | $1.83M 10-K · filed 2015-03-13 |
| 2013-12-31 | $3.19M 10-K · filed 2014-03-17 |
| 2012-12-31 | $1.69M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |